A codeine concentration of no more than 200 mg per 100 mL can place a qualifying preparation in Schedule V under controlled-substance rules. The formulation matters, too: other active ingredients and legal conditions help shape how a medicine is classified and regulated.

Multiple Choice

What is the compounded dose limit for codeine to classify as Schedule 5?

To classify codeine as a Schedule 5 controlled substance, the compounded dose limit is set at no more than 200 mg of codeine per 100 milliliters. This threshold is significant because it distinguishes Schedule 5 substances, which have a lower potential for abuse compared to those in higher schedules. The 200 mg per 100 milliliters limit is a regulatory measure to ensure that such preparations remain in a lower regulatory category, reflecting their accepted medical use and lower risk of addiction or dependence. It's important to understand that these regulations help maintain a balance between the availability of useful medications and the need to control substances that could be abused. The specific limit of 200 mg per 100 milliliters dictates how codeine can be formulated in pharmaceutical preparations without moving it into a higher schedule, which would impose stricter controls and limitations.

Codeine Concentration and Schedule V: Why the 200 mg Limit Matters

A small change in a medicine’s formulation can have a big effect on how the law treats it. For certain codeine preparations, the key threshold is no more than 200 milligrams of codeine per 100 milliliters. That limit helps distinguish a Schedule V preparation from codeine products subject to tighter controls.

The number may look like a simple measurement, but it sits within a broader framework of federal and Illinois controlled-substance law. Concentration matters; so do the preparation’s ingredients, intended medical use, and the rules that apply to the person dispensing it. Think of the limit as one piece of a regulatory puzzle, not a stand-alone permission slip.

What the 200 mg threshold means

Under the relevant Schedule V provision, a qualifying codeine preparation may contain no more than 200 mg of codeine per 100 mL, or, for certain solid preparations, no more than 200 mg per 100 grams. The codeine must also be combined with one or more nonnarcotic active ingredients in a way that fits the applicable legal description.

Put another way, a liquid containing 200 mg of codeine in 100 mL reaches the stated ceiling. A preparation with less than that amount may still need to meet the other requirements of the schedule. A product with more than 200 mg per 100 mL does not qualify for Schedule V under this concentration threshold and may fall under a more restrictive schedule, depending on its formulation and the governing law.

That distinction is important. The limit is not a general statement that any medicine below a certain concentration is automatically Schedule V. The details around the formulation matter, and pharmacy staff should check the exact statutory and regulatory language that applies.

Why controlled-substance schedules exist

Controlled-substance schedules group drugs according to factors that include accepted medical use and potential for misuse or dependence. The schedules shape how substances may be prescribed, stored, dispensed, recorded, and monitored. They create different levels of control rather than treating every medication with misuse potential as identical.

Codeine illustrates why this system can feel nuanced. It has legitimate medical uses, yet it can also cause sedation and dependence, especially when misused or taken in larger amounts than directed. A lower concentration in a qualifying combination product may place that preparation in a less restrictive category than a higher-strength codeine product. The law is drawing a line between formulations; it isn’t claiming that one is harmless and the other is dangerous in every circumstance.

This is a useful way to understand scheduling generally: the legal category follows the substance and the product’s precise form, not simply the familiar name on a label.

A concentration limit is not the whole rule

It’s tempting to see “200 mg per 100 mL” and stop there. But a concentration figure needs context. The relevant provision may also specify the type of product, the presence of other active ingredients, and the quantity or form in which the codeine appears.

For example, a codeine-containing liquid may meet the concentration ceiling but still need to satisfy the combination-product requirements. The nonnarcotic ingredient must be part of the preparation in a legally relevant way; its mere presence on a label may not settle every question. If a product’s composition is unusual, unclear, or changed, the pharmacist should verify how the applicable law classifies it rather than relying on a familiar product name.

This is where careful reading pays off. A product monograph, a wholesaler listing, or an old reference may help identify what a preparation contains, but classification is ultimately a legal question. When details don’t line up, consult current authoritative sources and the relevant regulatory guidance.

Federal and Illinois rules: check both

Pharmacy law often involves more than one layer of authority. Federal controlled-substance law sets national requirements, while Illinois law may add requirements or shape how controlled substances are handled within the state. A pharmacist working in Illinois needs to consider the applicable federal and state rules, along with current regulations and official guidance.

That means a product’s schedule is only one part of the compliance picture. Prescription requirements, dispensing limits, recordkeeping, storage, and other duties may depend on the specific substance, the product, and the current rules. A Schedule V classification does not mean “unregulated.” It means the substance is subject to a different level of control from substances in more restrictive schedules.

Rules can also change, and legal language can be more precise than a quick summary. When a formulation or a state-specific requirement is in question, check current sources such as the federal Controlled Substances Act and relevant Drug Enforcement Administration materials, as well as Illinois statutes and regulations. That extra step is much safer than relying on memory alone.

How to read a codeine formulation carefully

When reviewing a codeine product, it helps to move through the details in a steady order:

  • Confirm the amount of codeine. For a liquid, identify the quantity in milligrams and the corresponding volume. Don’t confuse the amount per dose with the amount per 100 mL.

  • Check the dosage form. The applicable rule may describe liquids and solid preparations differently.

  • Review the other active ingredients. A qualifying combination may need to include one or more nonnarcotic active ingredients.

  • Verify the current schedule. Use authoritative, up-to-date federal and Illinois sources.

  • Apply the relevant dispensing rules. Scheduling is only one element of the legal requirements for handling a medication.

These steps sound straightforward, but labels can present concentrations in different ways. A product might show the amount of codeine per 5 mL, per teaspoon, or per full bottle. Converting those figures to a common basis makes comparison easier. For instance, if a liquid contains 10 mg in 5 mL, that corresponds to 200 mg in 100 mL: 5 mL fits into 100 mL twenty times, so the codeine amount does too.

That sort of conversion can prevent a small arithmetic slip from becoming a larger classification error.

The public-health balance behind the rule

Controlled-substance law tries to balance two real concerns. Patients need access to useful medicines, and communities need safeguards against misuse and diversion. A concentration threshold helps define how certain formulations are categorized, but it doesn’t replace clinical judgment or sound dispensing controls.

Pharmacists remain part of that balance. They review prescriptions, consider patient-specific factors, and follow the legal requirements tied to the product being dispensed. A lower schedule may involve fewer restrictions than a higher one, yet responsible handling still matters. The substance can affect alertness, interact with other medicines, and pose risks when used outside its directions.

It’s also worth remembering that a legal category and a clinical risk assessment answer different questions. The schedule describes how the law regulates a substance or preparation. It does not, by itself, tell a clinician whether the medicine is right for a particular patient.

The takeaway

For a qualifying codeine preparation, the Schedule V concentration threshold is no more than 200 mg per 100 mL. The amount is a key part of classification, but it must be read alongside the formulation requirements and current federal and Illinois law.

In short: check the concentration, confirm the product details, and verify the applicable rules. That careful approach keeps the number in context—and helps ensure that useful medicines remain available under the safeguards the law requires.